Cargando…

Impact of Selected Small-Molecule Kinase Inhibitors on Lipid Membranes

Small-molecule protein kinase inhibitors are used for the treatment of various diseases. Although their effect(s) on the respective kinase are generally quite well understood, surprisingly, their interaction with membranes is only barely investigated; even though these drugs necessarily come into co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luck, Meike, Fischer, Markus, Werle, Maximilian, Scheidt, Holger A., Müller, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401620/ https://www.ncbi.nlm.nih.gov/pubmed/34451842 http://dx.doi.org/10.3390/ph14080746

Ejemplares similares

Binding of the small-molecule kinase inhibitor ruxolitinib to membranes does not disturb membrane integrity
por: Fischer, Markus, et al.
Publicado: (2020)

Membrane Interaction of Ibuprofen with Cholesterol-Containing Lipid Membranes
por: Kremkow, Jan, et al.
Publicado: (2020)

Effects of the RNA-Polymerase Inhibitors Remdesivir and Favipiravir on the Structure of Lipid Bilayers—An MD Study
por: Bringas, Mauro, et al.
Publicado: (2022)

Enzyme kinetics and distinct modulation of the protein kinase N family of kinases by lipid activators and small molecule inhibitors
por: Falk, Matthew D., et al.
Publicado: (2014)

Decoding kinase-adverse event associations for small molecule kinase inhibitors
por: Gong, Xiajing, et al.
Publicado: (2022)

Small molecule tyrosine kinase inhibitors in pancreatic cancer
por: Gupta, Sachin, et al.
Publicado: (2008)

An Update on Development of Small-Molecule Plasmodial Kinase Inhibitors
por: Moolman, Chantalle, et al.
Publicado: (2020)

Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer
por: Viganò, Mauro, et al.
Publicado: (2023)

Prediction of specificity-determining residues for small-molecule kinase inhibitors
por: Caffrey, Daniel R, et al.
Publicado: (2008)

Mechanism and consequences of RAF kinase activation by small-molecule inhibitors
por: Holderfield, M, et al.
Publicado: (2014)

Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase
por: Moccia, Marialuisa, et al.
Publicado: (2015)

Natamycin interferes with ergosterol-dependent lipid phases in model membranes
por: Akkerman, Vibeke, et al.
Publicado: (2023)

Interaction of the pitavastatin with model membranes
por: Shurshalova, Guzel S., et al.
Publicado: (2021)

In Vitro Selection of a DNA-Templated Small-Molecule Library Reveals a Class of Macrocyclic Kinase Inhibitors
por: Kleiner, Ralph E., et al.
Publicado: (2010)

Selective inhibition of intestinal guanosine 3′,5′-cyclic monophosphate signaling by small-molecule protein kinase inhibitors
por: Bijvelds, Marcel J. C., et al.
Publicado: (2018)

First‐in‐human study of deucravacitinib: A selective, potent, allosteric small‐molecule inhibitor of tyrosine kinase 2
por: Catlett, Ian M., et al.
Publicado: (2022)

Structure–activity exploration of a small-molecule Lipid II inhibitor
por: Fletcher, Steven, et al.
Publicado: (2015)

Towards Development of Small Molecule Lipid II Inhibitors as Novel Antibiotics
por: Chauhan, Jamal, et al.
Publicado: (2016)

Potential of Small Molecule Protein Tyrosine Kinase Inhibitors as Immunomodulators and Inhibitors of the Development of Diabetes
por: Little, Peter J., et al.
Publicado: (2009)

Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin
por: Huertas, D, et al.
Publicado: (2012)

Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT
por: Hicks, Justin W., et al.
Publicado: (2010)

Small molecule inhibitors of cyclin-dependent kinase 9 for cancer therapy
por: Alsfouk, Aisha
Publicado: (2021)

Fusion of Bipolar Tetraether Lipid Membranes Without Enhanced Leakage of Small Molecules
por: Leriche, Geoffray, et al.
Publicado: (2019)

Identification of a Kinase Profile that Predicts Chromosome Damage Induced by Small Molecule Kinase Inhibitors
por: Olaharski, Andrew J., et al.
Publicado: (2009)

Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases
por: Moccia, Marialuisa, et al.
Publicado: (2021)

Stafiba: A STAT5‐Selective Small‐Molecule Inhibitor
por: Eckhardt, Katrin S., et al.
Publicado: (2022)

HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors
por: Spector, Neil, et al.
Publicado: (2007)

New targets for therapy in breast cancer: Small molecule tyrosine kinase inhibitors
por: Lin, Nancy U, et al.
Publicado: (2004)

Phenotypic Fingerprinting of Small Molecule Cell Cycle Kinase Inhibitors for Drug Discovery
por: Low, Jonathan, et al.
Publicado: (2009)

Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of doxorubicin
por: Wong, John, et al.
Publicado: (2013)

Small Molecule Substrate Phosphorylation Site Inhibitors of Protein Kinases: Approaches and Challenges
por: Breen, Meghan E., et al.
Publicado: (2014)

Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors
por: Arter, Chris, et al.
Publicado: (2022)

The small molecule fenpropimorph rapidly converts chloroplast membrane lipids to triacylglycerols in Chlamydomonas reinhardtii
por: Kim, Hanul, et al.
Publicado: (2015)

Lysis of membrane lipids promoted by small organic molecules: Reactivity depends on structure but not lipophilicity
por: Britt, Hannah M., et al.
Publicado: (2020)

The Potential of α-Spinasterol to Mimic the Membrane Properties of Natural Cholesterol
por: Haralampiev, Ivan, et al.
Publicado: (2017)

Efficacy of the small molecule inhibitor of Lipid II BAS00127538 against Acinetobacter baumannii
por: de Leeuw, Erik PH
Publicado: (2014)

Small Molecule Kinase Inhibitors Provide Insight into Mps1 Cell Cycle Function
por: Kwiatkowski, Nicholas, et al.
Publicado: (2010)

A Small-Molecule Inhibitor of PIM Kinases as a Potential Treatment for Urothelial Carcinomas()()
por: Foulks, Jason M., et al.
Publicado: (2014)

Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
por: Hojjat-Farsangi, Mohammad
Publicado: (2014)

Identification and Characterization of a Small-Molecule Inhibitor of Death-Associated Protein Kinase 1
por: Wilbek, Theis S, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_24egtlnc03tr0mg29eqnbdqjn1